MC
PFE icon

Miles Capital’s Pfizer PFE Stock Holding History

Miles Capital’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		$530K Sell
17,121
-213
-1% -$7.26K 0.57% 49
2019
Q4 		$644K Sell
17,334
-1,935
-10% -$68.9K 0.52% 54
2019
Q3 		$657K Sell
19,269
-2,105
-10% -$76.5K 0.54% 51
2019
Q2 		$878K Sell
21,374
-9,141
-30% -$363K 0.72% 38
2019
Q1 		$1.23M Buy
30,515
+75
+0.2% +$3K 1.07% 18
2018
Q4 		$1.26M Sell
30,440
-7,852
-21% -$326K 1.24% 14
2018
Q3 		$1.6M Sell
38,292
-7,739
-17% -$298K 1.3% 12
2018
Q2 		$1.58M Sell
46,031
-627
-1% -$21.4K 0.98% 11
2018
Q1 		$1.57M Buy
46,658
+3,471
+8% +$119K 0.87% 15
2017
Q4 		$1.48M Sell
43,187
-527
-1% -$18K 0.86% 19
2017
Q3 		$1.48M Sell
43,714
-2,161
-5% -$69.5K 0.84% 12
2017
Q2 		$1.46M Buy
45,875
+4,845
+12% +$153K 0.79% 14
2017
Q1 		$1.33M Sell
41,030
-3,377
-8% -$106K 0.74% 20
2016
Q4 		$1.37M Buy
44,407
+3,053
+7% +$93.2K 0.84% 22
2016
Q3 		$1.33M Buy
41,354
+5,233
+14% +$175K 0.9% 19
2016
Q2 		$1.21M Sell
36,121
-2,167
-6% -$69.2K 0.82% 14
2016
Q1 		$1.08M Sell
38,288
-111
-0.3% -$3.17K 0.72% 28
2015
Q4 		$1.18M Sell
38,399
-189
-0.5% -$5.95K 0.8% 23
2015
Q3 		$1.15M Sell
38,588
-688
-2% -$22.1K 0.83% 25
2015
Q2 		$1.25M Sell
39,276
-14,784
-27% -$482K 0.82% 25
2015
Q1 		$1.78M Sell
54,060
-2,692
-5% -$85.6K 1.06% 14
2014
Q4 		$1.68M Sell
56,752
-10,335
-15% -$296K 0.9% 25
2014
Q3 		$1.88M Buy
67,087
+19,946
+42% +$560K 1% 26
2014
Q2 		$1.33M Sell
47,141
-473
-1% -$13.5K 0.67% 46
2014
Q1 		$1.45M Buy
+47,614
New +$1.42M 0.75% 41

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

Miles Capital's PFE Position: Q1 2020 in Review

Miles Capital reduced its Pfizer (PFE) stake by 1.2% in Q1 2020, selling an estimated $7.26K and leaving 17,121 shares worth $530K. The position accounts for 0.57% of the portfolio, ranked #49.

Miles Capital first reported a position in PFE in Q1 2014 and has held it in 25 quarters since. The position peaked at $1.88M in Q3 2014. 2,436 funds tracked by Wall St. Rank hold PFE as of Q1 2020.

  • Miles Capital held 17,121 shares of Pfizer worth $530K as of Q1 2020.
  • Miles Capital sold 213 Pfizer shares in Q1 2020, an estimated $7.26K.
  • Pfizer made up 0.57% of Miles Capital's portfolio in Q1 2020, its #49 holding.
  • Miles Capital first reported a position in Pfizer in Q1 2014 and has held it in 25 quarters since.
  • Miles Capital's Pfizer position peaked at $1.88M in Q3 2014.
  • 2,436 funds tracked by Wall St. Rank held Pfizer as of Q1 2020.

Based on Miles Capital's 13F filing for Q1 2020, filed 13 May 2020.